论文部分内容阅读
目的 :探讨盐酸丁咯地尔治疗椎基底动脉供血不足的临床疗效。方法将72例诊断为椎基底动脉供血不足的患者随机分为2组 ,盐酸丁咯地尔治疗组38例 ,低分子右旋糖酐加维脑路通治疗为对照组34例。结果治疗组痊愈23例 ,有效13例 ,总有效率94 7 % ;对照组痊愈11例 ,有效9例 ,总有效率58 8 % ,P<0 01。结论 :盐酸丁咯地尔治疗椎基底动脉供血不足疗效明显优于低分子右旋糖酐加维脑路通治疗 ,是治疗椎基底动脉供血不足的理想药物。
Objective: To investigate the clinical efficacy of buflomedil hydrochloride in the treatment of vertebrobasilar insufficiency. Methods Seventy-two patients diagnosed as vertebrobasilar insufficiency were randomly divided into two groups: 38 cases in buflomedil hydrochloride group and 34 cases in control group with low-molecular dextran and verapamil. Results In the treatment group, 23 cases were cured, 13 cases were effective, and the total effective rate was 94.7%. In the control group, 11 cases were cured and 9 cases were effective. The total effective rate was 58.8%, P <0.01. CONCLUSION: Buflomedil hydrochloride is superior to low molecular weight dextran and Jiaweiluotong in the treatment of vertebrobasilar insufficiency. It is an ideal drug for the treatment of vertebrobasilar insufficiency.